LC-MS: Robust long-term Vanquish Neo UHPLC system operation enabling high-performance high-pressure nanoLC separations

Importance of the Topic

Liquid chromatography–mass spectrometry (LC-MS) at nanoflow rates is a cornerstone of bottom-up proteomics due to its high sensitivity and resolution. However, widespread adoption has been limited by challenges in system robustness, reproducibility, column blockages, and low sample throughput. Demonstrating reliable long-term performance under high back-pressure conditions is critical to enabling routine nanoLC-MS analyses in research and quality-control settings.

Study Objectives and Overview

This study evaluated the next-generation Thermo Scientific Vanquish Neo UHPLC system paired with a 75 µm × 50 cm PepMap Neo column under nano-flow conditions. Over 176 days and 1,600 consecutive injections of a bovine serum albumin (BSA) digest, the goal was to assess chromatographic consistency, column back-pressure stability, and system robustness when operating at up to 1,500 bar.

Methodology and Instrumentation

The workflow combined sample preparation, solvent composition, system parameters, and hardware features designed for high-pressure nanoLC:

• Sample: 1 pmol/µL BSA digest in 0.1 % formic acid.
• UHPLC system: Thermo Scientific Vanquish Neo with binary pump, autosampler, thermostatted column compartment (50 °C), and UV detector at 214 nm.
• Column: Thermo Scientific PepMap Neo, 75 µm × 50 cm, 2 µm particles, rated to 1,500 bar.
• Fluidics: nanoViper capillaries, MicroTight adaptors, integrated frit at needle seat, SmartInject for pressure ramping.
• Solvents: mobile phase A (water/0.1 % formic acid), B (80/20 acetonitrile/water/0.1 % formic acid).
• Gradient: 90 min nano-flow gradient at 300 nL/min from 6 % to 35 % B, followed by column wash and equilibration exploiting fast loading/equilibration modes.

Main Results and Discussion

Retention times of eight selected BSA peptides remained stable throughout 1,600 injections, with standard deviations below 0.3 min per 100-injection interval. Full width at half maximum (FWHM) values showed no systematic increase, indicating consistent resolution over six months. Column back pressure measured one minute into the gradient varied by less than 25 bar across all injections. These results reflect the efficacy of controlled flow ramping, integrated frit filtration, and high-pressure loading in maintaining column integrity and chromatographic performance over extended use.

Benefits and Practical Applications

Consistent long-term performance under high back pressure enables:

• Routine nanoLC-MS workflows in proteomics laboratories.
• Reduced downtime and maintenance due to fewer blockages and pressure shocks.
• Improved sample throughput through fast column loading and equilibration at 1,500 bar.
• High sensitivity and solvent savings without sacrificing robustness or reproducibility.

Future Trends and Opportunities

Advances in low-flow UHPLC systems and column chemistries will further drive nanoLC-MS adoption in both research and regulated environments. Emerging trends include tighter integration with high-resolution mass spectrometers, automated method optimization, and online quality-control diagnostics. These developments will support deeper proteome coverage, higher throughput, and broader applicability across biomarker discovery, clinical research, and industrial analytics.

Conclusion

The Vanquish Neo UHPLC system combined with PepMap Neo columns demonstrated unprecedented robustness and reproducibility for long-term nanoLC operations at high pressure. Stable retention times, consistent peak widths, and minimal pressure drift over 1,600 injections validate its suitability for demanding bottom-up proteomics workflows, paving the way for routine, high-performance nanoLC-MS analyses in diverse laboratory settings.